Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates · Delayed Price · Currency is AED

1.050

+0.020 (1.94%)

At close: Aug 13, 2026

ADX:JULPHAR Financials Overview

Financials in millions AED. Fiscal year is January - December.

Millions AED. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,067	1,076	992.2	1,278	1,616	1,143
Revenue Growth	13.84%	8.39%	-22.33%	-20.95%	41.37%	99.51%
Gross Profit	447.1	435.9	407.1	425.1	557.9	383.4
Operating Income	73	54.2	46	-24.5	-28.6	41.5
Net Income	81.4	172.2	44.6	-99.1	-29.4	64.4
Earnings Per Share	0.07	0.15	0.04	-0.09	-0.03	0.06
EPS Growth	-51.69%	286.11%	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Trading	440.4	432.6	416.7	-	-	-
Manufacturing	876.3	913.1	814.7	794.4	886.4	699
Eliminations	-249.7	-270.2	-239.2	-223.6	-275.6	-
Total	1,067	1,076	992.2	1,278	1,616	1,143

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	261.7	268.6	168.6	225.3	111.8	178.8
Total Debt	274.3	275	971	1,111	885.7	819.1
Net Cash (Debt)	-12.6	-6.4	-802.4	-885.3	-773.9	-640.3
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.01	-0.01	-0.69	-0.77	-0.67	-0.55

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	132.4	120.9	190	93.6	19.3	46.2
Capital Expenditures	-36.7	-35.7	-43.7	-22.1	-63.7	-44.4
Free Cash Flow	95.7	85.2	146.3	71.5	-44.4	1.8
Free Cash Flow Growth	22.22%	-41.76%	104.61%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.90%	40.53%	41.03%	33.28%	34.52%	33.54%
Operating Margin	6.84%	5.04%	4.64%	-1.92%	-1.77%	3.63%
Pretax Margin	7.14%	4.41%	-0.67%	-5.46%	-2.07%	3.73%
Profit Margin	7.63%	16.01%	4.50%	-7.76%	-1.82%	5.63%
FCF Margin	8.97%	7.92%	14.74%	5.60%	-2.75%	0.16%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.43	7.85	33.67	-	-	33.01
Forward PE	13.13	21.27	52.00	57.00	21.09	16.64
P/FCF Ratio	44.43	15.86	10.27	12.43	-	1180.90
PS Ratio	1.03	1.26	1.51	0.70	0.83	1.86